Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Hypercholesterolemia: HELP
Nihar R. Desai
Based on 5 articles published since 2007
||||
Expertise Level
The expertise of Nihar R. Desai ranks in the
  • Top 0.19%
  • ... of 29,430 published authors worldwide on Hypercholesterolemia
  • ... from 2007 through 2018
  • ... based on contributions to 5 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Work Locations
Details
Most likely:    Yale University   Contact    
2015
  • Section of Cardiovascular Medicine, Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, Yale School of Medicine, New Haven, CT. · TIMI study Group, Division of Cardiovascular Medicine, Brigham and Women׳s Hospital, Harvard Medical School, Boston, MA. Electronic address: · Pubmed 25771732
Probable:    Harvard University   Contact    
2014
  • TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Division of Cardiovascular Medicine, University of California at San Francisco, San Francisco, California. · Amgen, Inc., Thousand Oaks, California. · TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: · Pubmed 24161333
2013
  • TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. · Pubmed 23884353
2012
  • TIMI Study Group, Brigham and Women's Hospital, Boston, MA, USA. · Pubmed 23141813
  • TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. · Pubmed 22714699
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Nihar R. Desai in 2007-2018 about Hypercholesterolemia:

  • PCSK9 inhibition in patients with hypercholesterolemia. 2015
  • AMG 145, a monoclonal antibody against PCSK9, facilitates achievement of national cholesterol education program-adult treatment panel III low-density lipoprotein cholesterol goals among high-risk patients: an analysis from the LAPLACE-TIMI 57 trial (LDL-C assessment with PCSK9 monoclonal antibody inhibition combined with statin thErapy-thrombolysis in myocardial infarction 57). 2014
  • AMG145, a monoclonal antibody against proprotein convertase subtilisin kexin type 9, significantly reduces lipoprotein(a) in hypercholesterolemic patients receiving statin therapy: an analysis from the LDL-C Assessment with Proprotein Convertase Subtilisin Kexin Type 9 Monoclonal Antibody Inhibition Combined with Statin Therapy (LAPLACE)-Thrombolysis in Myocardial Infarction (TIMI) 57 trial. 2013
  • Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase 2 study. 2012
  • Design and rationale of the LAPLACE-TIMI 57 trial: a phase II, double-blind, placebo-controlled study of the efficacy and tolerability of a monoclonal antibody inhibitor of PCSK9 in subjects with hypercholesterolemia on background statin therapy. 2012
Show List of Full Article Records
Google Searches

Learn more about Nihar R. Desai using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Yale University
Harvard University
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Yale University
2015
  • Section of Cardiovascular Medicine, Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, Yale School of Medicine, New Haven, CT. · TIMI study Group, Division of Cardiovascular Medicine, Brigham and Women׳s Hospital, Harvard Medical School, Boston, MA. Electronic address: · Pubmed 25771732
Harvard University
2014
  • TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Division of Cardiovascular Medicine, University of California at San Francisco, San Francisco, California. · Amgen, Inc., Thousand Oaks, California. · TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: · Pubmed 24161333
2013
  • TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. · Pubmed 23884353
2012
  • TIMI Study Group, Brigham and Women's Hospital, Boston, MA, USA. · Pubmed 23141813
  • TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. · Pubmed 22714699
Yearly article counts 000111200000
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.